WARNING
This guidance is under active development by NHS England and content may be added or updated on a regular basis.What is Multi-cancer Early Detection?
This implementation guide provides guidance on implementing the Multi-cancer Early Detection Test Report FHIR R4 message.
A Multi-cancer Early Detection Test is based on a blood sample that is analysed for cancer markers. If markers are detected, the test can predict the probable body site that is the cancer origin.
Licence
Licensing and Publisher
- Copyright© 2023+ NHS England Licensed under the Apache License, Version 2.0 (the "License"); you may not use this file except in compliance with the License. You may obtain a copy of the License at http://www.apache.org/licenses/LICENSE-2.0 Unless required by applicable law or agreed to in writing, software distributed under the License is distributed on an "AS IS" BASIS, WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or implied. See the License for the specific language governing permissions and limitations under the License. HL7® FHIR® standard Copyright © 2011+ HL7 The HL7® FHIR® standard is used under the FHIR license. You may obtain a copy of the FHIR license at https://www.hl7.org/fhir/license.html.
- Developed and authored by NHS England Interoperability Team.